Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PCDH9 | Q9HC56 | Protocadherin-9 | 1 | Adhesion and uptake mediation | 1 | 0.40 | ||||
| PCFT | Q96NT5 | Proton-coupled folate transporter (HsPCFT) (hPCFT) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1) | Disease related genesEssential proteinsHuman disease related genes | 12 | Folate deficiency anaemiaLeukaemiaNutritional deficiency | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.40 | ||
| PDCD1 | Q15116 | Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279) | CD markersDisease related genesFDA approved drug targets | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.40 | |||
| PDE3A | Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE) | Disease related genesEnzymesFDA approved drug targets | 6 | Arterial occlusive diseaseAsthmaCardiovascular disease | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.40 | ||
| PDPN | Q86YL7 | Podoplanin (Aggrus) (Glycoprotein 36) (Gp36) (PA2.26 antigen) (T1-alpha) (T1A) [Cleaved into: 29kDa cytosolic podoplanin intracellular domain (PICD)] | Predicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.40 | |||
| PE2R3 | P43115 | Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaChronic arterial occlusive diseaseGlaucoma | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.40 | ||
| PGFRB | P09619 | Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) | Cancer-related genesCD markersDisease related genes | 1 | Acute diabetic complicationAlzheimer diseaseGram-positive bacterial infection | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.40 | ||
| PGRC2 | O15173 | Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6) | Predicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.40 | |||
| PHEX | P78562 | Phosphate-regulating neutral endopeptidase PHEX (EC 3.4.24.-) (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein) (HYP) | 1 | Metabolism mediation | 1 | 0.40 | ||||
| PI2R | P43119 | Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor) | 7 | AbortionArterial occlusive diseaseAsthma | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.40 |